Novel risk factors for atherosclerosis
- PMID: 10761492
- DOI: 10.4065/75.4.369
Novel risk factors for atherosclerosis
Abstract
In the past several years, evidence has accumulated that factors other than conventional risk factors may contribute to the development of atherosclerosis. Conventional risk factors predict less than one half of future cardiovascular events. Furthermore, conventional risk factors may not have the same causal effect in different ethnic groups in whom novel risk factors may have a role. These newer risk factors for atherosclerosis include homocysteine, fibrinogen, impaired fibrinolysis, increased platelet reactivity, hypercoagulability, lipoprotein(a), small dense low-density lipoprotein cholesterol, and inflammatory-infectious markers. Identification of other markers associated with an increased risk of atherosclerotic vascular disease may allow better insight into the pathobiology of atherosclerosis and facilitate the development of preventive and therapeutic measures. In this review, we discuss the evidence associating these factors in the pathogenesis of atherosclerosis, the mechanism of risk, and the clinical implications of this knowledge.
Comment in
-
Inherited thrombophilia, hypercoagulability, and risk factors for atherosclerosis.Mayo Clin Proc. 2000 Aug;75(8):870-1. doi: 10.4065/75.8.870-a. Mayo Clin Proc. 2000. PMID: 10943248 No abstract available.
Similar articles
-
[Novel risk factors for atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a) and cholesterol as predictors of peripheral arteriopathy].Ital Heart J Suppl. 2001 Sep;2(9):1031-3. Ital Heart J Suppl. 2001. PMID: 11675827 Italian. No abstract available.
-
Conditional risk factors for atherosclerosis.Mayo Clin Proc. 2005 Feb;80(2):219-30. doi: 10.4065/80.2.219. Mayo Clin Proc. 2005. PMID: 15704777 Review.
-
[Homocysteine--CRP--lipoprotein (a). When do you evaluate the "new" risk factors].MMW Fortschr Med. 2001 Jan 25;143(4):22-4. MMW Fortschr Med. 2001. PMID: 11219276 German.
-
Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence.JAMA. 2003 Aug 20;290(7):932-40. doi: 10.1001/jama.290.7.932. JAMA. 2003. PMID: 12928471 Review.
-
Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.J Rheumatol. 2002 May;29(5):875-82. J Rheumatol. 2002. PMID: 12022343
Cited by
-
Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes.Pediatr Diabetes. 2007 Apr;8(2):74-87. doi: 10.1111/j.1399-5448.2007.00237.x. Pediatr Diabetes. 2007. PMID: 17448130 Free PMC article. Clinical Trial.
-
Pneumococcal vaccination and risk of myocardial infarction.CMAJ. 2008 Oct 7;179(8):773-7. doi: 10.1503/cmaj.070221. CMAJ. 2008. PMID: 18838452 Free PMC article.
-
Regulatory metabolites of vitamin E and their putative relevance for atherogenesis.Redox Biol. 2014 Feb 19;2:495-503. doi: 10.1016/j.redox.2014.02.002. eCollection 2014. Redox Biol. 2014. PMID: 24624339 Free PMC article. Review.
-
Modulating human aging and age-associated diseases.Biochim Biophys Acta. 2009 Oct;1790(10):1133-8. doi: 10.1016/j.bbagen.2009.02.002. Epub 2009 Feb 10. Biochim Biophys Acta. 2009. PMID: 19364477 Free PMC article. Review.
-
Atherosclerosis and antiphospholipid syndrome.Clin Rev Allergy Immunol. 2003 Aug;25(1):79-88. doi: 10.1385/CRIAI:25:1:79. Clin Rev Allergy Immunol. 2003. PMID: 12794263 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous